S2P, Science to Practice, Ltd.   Report issue

For profit Phase 2
Founded: Ljubljana Slovenia (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2016
NCT03440125
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

S2P, Ltd. | S2P, Science to Practice, Ltd.

Active Ingredients

Drugs in Phase 2 Trials (1)

cayenne pepper (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 2)

Low Back Pain (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1